Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,495,983 papers from all fields of science
Search
Sign In
Create Free Account
Databases, Chemical
Known as:
Chemical Database
, Chemical Databases
, Database, Chemical
Databases devoted to knowledge about specific chemicals.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Databases, Molecular
legislation & jurisprudence
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
An integrated strategy for rapid discovery and identification of quality markers in Guanxin Kangtai preparation using UHPLC-TOF/MS and multivariate statistical analysis.
Ting-bo Chen
,
Yi-Han Zuo
,
Gengting Dong
,
Liang Liu
,
Hua Zhou
Phytomedicine
2018
Corpus ID: 3981907
2015
2015
Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling
R. Kumar
,
Minky Son
,
+9 authors
Keun Woo Lee
Acta Pharmacologica Sinica
2015
Corpus ID: 205817
Aim:Recent evidence suggests that aldo-keto reductase family 1 B10 (AKR1B10) may be a potential diagnostic or prognostic marker…
Expand
Highly Cited
2012
Highly Cited
2012
MolFind: a software package enabling HPLC/MS-based identification of unknown chemical structures.
Lochana C. Menikarachchi
,
Shannon Cawley
,
+5 authors
David F. Grant
Analytical Chemistry
2012
Corpus ID: 206356540
In this paper, we present MolFind, a highly multithreaded pipeline type software package for use as an aid in identifying…
Expand
2012
2012
Prediction Models of P-Glycoprotein Substrates Using Simple 2D and 3D Descriptors by a Recursive Partitioning Approach
Jong Young Joung
,
Hyoungjoon Kim
,
H. Kim
,
S. Ahn
,
Ky-Youb Nam
,
K. No
2012
Corpus ID: 55020351
E-mail: kyn@youai.co.krReceived October 31, 2011, Accepted December 21, 2011P-gp (P-glycoprotein) is a member of the ATP binding…
Expand
2010
2010
Self-similar behavior and chemistry tabulation of burnt-gas diluted premixed flamelets including heat-loss
K. Wang
,
G. Ribert
,
P. Domingo
,
L. Vervisch
2010
Corpus ID: 96961022
In many combustion systems, the reactive gases feeding the reaction zones are diluted by burnt products, to favor flame…
Expand
2010
2010
In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
K. Nolan
,
M. C. Caraher
,
M. Humphries
,
Hoda Abdel-Aal Bettley
,
R. Bryce
,
I. Stratford
Bioorganic & Medicinal Chemistry Letters
2010
Corpus ID: 33523988
2008
2008
Discovery of a Drug‐Like G‐Quadruplex Binding Ligand by High‐Throughput Docking
Dik‐Lung Ma
,
T. Lai
,
+4 authors
Kwok‐yin Wong
ChemMedChem
2008
Corpus ID: 438329
There has been considerable interest in the study of G-quadruplex DNA owing to its involvement in the regulation of telomerase…
Expand
2008
2008
Combating the threat of anthrax: a quantitative structure-activity relationship approach.
R. Verma
,
C. Hansch
Molecular Pharmaceutics
2008
Corpus ID: 5305340
Bacterial agents or products more likely to be used as biological weapons of mass destruction are Bacillus anthracis, Francisella…
Expand
2006
2006
A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist
Nidhi Singh
,
G. Chevé
,
D. Ferguson
,
C. McCurdy
J. Comput. Aided Mol. Des.
2006
Corpus ID: 13774089
Combined ligand-based and target-based drug design approaches provide a synergistic advantage over either method individually…
Expand
1998
1998
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
R. Wilcox
,
Tom Tseng
,
+6 authors
K. Neve
Journal of Medicinal Chemistry
1998
Corpus ID: 22812612
We have previously shown that using agonist affinity at recombinant receptors selectively expressed in clonal cells as the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE